...
首页> 外文期刊>Heart failure reviews >Idiopathic giant cell myocarditis and cardiac sarcoidosis
【24h】

Idiopathic giant cell myocarditis and cardiac sarcoidosis

机译:特发性巨细胞心肌炎和心脏结节病

获取原文
获取原文并翻译 | 示例
           

摘要

Idiopathic giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare disorders that cause cardiomyopathy, often with ventricular arrhythmias or heart block. Infection, autoimmune processes, and genetics have all been implicated in the pathogenesis of these diseases, but the etiology for both diseases is likely a complex multifactorial process. Both GCM and CS are generally progressive despite treatment with standard heart failure and arrhythmia therapies. Making the diagnosis of GCM or CS on initial clinical presentation is possible in only a small percentage of patients, so myocardial tissue diagnosis is required. The use of multiple noninvasive imaging modalities may aid in diagnosis and assessment of response to treatment. Establishing the diagnosis of GCM or CS early is crucial, as tailored immunosuppressive treatment may significantly alter the clinical course of these patients. The prognosis of patients with GCM is poor, while the prognosis for patients with CS varies according to degree of left ventricular dysfunction.
机译:特发性巨细胞心肌炎(GCM)和心脏结节病(CS)是引起心肌病的罕见疾病,通常伴有室性心律不齐或心脏传导阻滞。感染,自身免疫过程和遗传学都与这些疾病的发病机制有关,但是两种疾病的病因可能都是复杂的多因素过程。尽管采用标准的心力衰竭和心律不齐疗法进行治疗,但GCM和CS均通常是进行性的。仅在一小部分患者中可以在最初的临床表现中进行GCM或CS的诊断,因此需要进行心肌组织诊断。多种非侵入性成像方式的使用可能有助于诊断和评估对治疗的反应。尽早建立GCM或CS的诊断至关重要,因为量身定制的免疫抑制治疗可能会大大改变这些患者的临床病程。 GCM患者的预后较差,而CS患者的预后因左心功能不全的程度而异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号